Study S000061

Assessment of Pancreatic Beta Cell Mass and Function with the Aid of Positron Emission Tomography Imaging in Human Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05662189
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Masking: NONE
Status: RECRUITING
Enrollment: 70
Start: 2022-03-15
Primary completion: 2025-07
Lead sponsor: Azienda Ospedaliero-Universitaria di Parma
Conditions: Type1diabetes; Type2diabetes; Pre Diabetes; Hyperinsulinism
Interventions: DRUG:68Ga-exendin-4; OTHER:mixed meal test
Results posted: FALSE

Registered primary outcomes

BCF x M [through study completion, an average of 3 months after enrolment]
pancreatic beta cell mass (BCM) [through study completion, an average of 3 months after enrolment]
pancreatic beta cell function (BCF) [through study completion, an average of 3 months after enrolment]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.